, Tracking Stock Market Picks
Enter Symbol:
St. Jude Medical, Inc. (STJ) [hlAlert]

up 71.87 %

St. Jude Medical, Inc. (STJ) rated Buy with price target $49 by Jefferies

Posted on: Monday,  Apr 12, 2010  8:25 AM ET by Jefferies

Jefferies rated Buy St. Jude Medical, Inc. (NYSE: STJ) on 04/12/2010, when the stock price was $42.14. Since
then, St. Jude Medical, Inc. has gained 71.88% as of 01/28/2016's recent price of $72.43.
If you would have followed this Jefferies's recommendation on STJ, you would have gained 71.87% of your investment in 2117 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/12/2010 8:25 AM Buy
42.14 49.00
as of 12/31/2010
1 Week up  0.21 %
1 Month up  10.00 %
3 Months up  8.18 %
1 YTD up  0.99 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy